(Q37965600)

26 August 2017

title

Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies (English)

1 reference

26 August 2017

1 reference

1 reference

1 reference

David I Hong

1

1 reference

26 August 2017

Lora Bankova

2

1 reference

26 August 2017

Katherine N Cahill

3

1 reference

26 August 2017

Timothy Kyin

4

1 reference

26 August 2017

Mariana C Castells

5

1 reference

26 August 2017

publication date

1 January 2012

1 reference

Expert Review of Clinical Immunology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

43-52; quiz 53-4

1 reference

Acute infusion reactions induced by monoclonal antibody therapy

26 August 2017

cites work

1 reference

Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases

21 January 2018

1 reference

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions.

21 January 2018

1 reference

Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis

21 January 2018

1 reference

Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease

21 January 2018

1 reference

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

21 January 2018

1 reference

Clinical features and severity grading of anaphylaxis

21 January 2018

1 reference

Etanercept: an overview of dermatologic adverse events.

21 January 2018

1 reference

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose

21 January 2018

1 reference

Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer.

21 January 2018

1 reference

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

21 January 2018

1 reference

Six cases of treatment with panitumumab in patients with severe hypersensitivity reactions to cetuximab.

21 January 2018

1 reference

Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication

21 January 2018

1 reference

Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer

21 January 2018

1 reference

Managing premedications and the risk for reactions to infusional monoclonal antibody therapy

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.11.75

1 reference

26 August 2017

1 reference